The gastrointestinal endoscopic devices market in the UK is expected to reach a projected revenue of US$ 285.3 million by 2030. A compound annual growth rate of 3.3% is expected of the UK gastrointestinal endoscopic devices market from 2025 to 2030.
Stryker Corp, Boston Scientific Corp, Johnson & Johnson, FUJIFILM Holdings Corp, Conmed Corp
Other key industry trends
In terms of revenue, UK accounted for 2.1% of the global gastrointestinal endoscopic devices market in 2024.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
In Europe, Germany gastrointestinal endoscopic devices market is projected to lead the regional market in terms of revenue in 2030.
Denmark is the fastest growing regional market in Europe and is projected to reach USD 200.4 million by 2030.
According to Cancer Research UK, globally 17 million cancer cases were diagnosed in 2018, and this number is estimated to reach 27.5 million in 2040, leading to an incremental growth in cancer surgeries and demand for endoscopy. It is estimated that in every 2 minutes, an individual is diagnosed with cancer in the UK.
High prevalence of cancer & chronic diseases and growing geriatric population are among factors expected to drive the growth of gastrointestinal endoscopy devices market. The introduction of National Awareness and Early Diagnosis Initiative (NAEDI) has facilitated early diagnosis of cancers, along with increased access to optimal treatment, thereby playing a vital role in driving the market growth.
Lack of qualified surgeons and trained professionals hampers the Endoscopic Ultrasound (EUS) segment of the market. To overcome this, a working group from British Society of Gastroenterology recommended that trainees must complete 250 EUS procedures, which includes 20 sub epithelial lesions, 150 pancreatobiliary cases, and 80 luminal cancer cases.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Gastrointestinal Endoscopic Devices Market will help companies and investors design strategic landscapes.
Flexible Gastrointestinal Endoscopes was the largest segment with a revenue share of 51.66% in 2024.
Horizon Databook has segmented the U.K. gastrointestinal endoscopic devices market based on rigid gastrointestinal endoscopes, flexible gastrointestinal endoscopes, disposable gastrointestinal endoscopes covering the revenue growth of each sub-segment from 2018 to 2030.
According to Cancer Research UK, globally 17 million cancer cases were diagnosed in 2018, and this number is estimated to reach 27.5 million in 2040, leading to an incremental growth in cancer surgeries and demand for endoscopy. It is estimated that in every 2 minutes, an individual is diagnosed with cancer in the UK.
High prevalence of cancer & chronic diseases and growing geriatric population are among factors expected to drive the growth of gastrointestinal endoscopy devices market. The introduction of National Awareness and Early Diagnosis Initiative (NAEDI) has facilitated early diagnosis of cancers, along with increased access to optimal treatment, thereby playing a vital role in driving the market growth.
Lack of qualified surgeons and trained professionals hampers the Endoscopic Ultrasound (EUS) segment of the market. To overcome this, a working group from British Society of Gastroenterology recommended that trainees must complete 250 EUS procedures, which includes 20 sub epithelial lesions, 150 pancreatobiliary cases, and 80 luminal cancer cases.
U.K. Gastrointestinal Endoscopic Devices Market Product Outlook (Revenue, USD Million , 2018-2030)
Rigid Gastrointestinal Endoscopes
Flexible Gastrointestinal Endoscopes
Disposable Gastrointestinal Endoscopes
U.K. Gastrointestinal Endoscopic Devices Market End Use Outlook (Revenue, USD Million , 2018-2030)
Hospitals
Outpatient Facilities
Reasons to subscribe to gastrointestinal endoscopic devices market databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of gastrointestinal endoscopic devices market databook
Our clientele includes a mix of gastrointestinal endoscopic devices market companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.K. gastrointestinal endoscopic devices market, including forecasts for subscribers. This country databook contains high-level insights into U.K. gastrointestinal endoscopic devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.